As it is not possible by expert pathologists to classify a glioma as IDH-mutant or IDH-wildtype on the basis of the simple visual inspection of the H&E stained histological specimen of glioma, these are encouraging results. This evidence concerns the gene IDH2 and central nervous system cancer.